Author: James Hallifax

The DEA Backs Down, Will Not Criminalize 5 Psychedelics

July 28, 2022June 2, 2024 Act, Policy

This week the DEA announced it would withdraw its plan to schedule 5 research psychedelics. But we shouldn’t celebrate just yet

July 27, 2022June 2, 2024 Business, Learn, Research

Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers

July 22, 2022June 2, 2024 Business, Learn, Stock Reports

Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research

July 19, 2022June 2, 2024 Business, Learn, News

George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?

July 19, 2022June 2, 2024 Learn, Uncategorized

Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks

July 14, 2022June 2, 2024 Culture, Learn

The Netflix documentary ‘How to Change Your Mind’ is great TV even though it fails to provide balanced coverage of psychedelics

July 13, 2022June 2, 2024 Culture, Policy, Travel

People around the world are learning about the mental health benefits of psychedelics. Here are 5 countries where psychedelics are legal.

July 12, 2022June 2, 2024 Culture, Learn

Michael Pollan’s landmark book is now a streaming miniseries, but is the Netflix psychedelics documentary worth the watch?

July 11, 2022June 2, 2024 Business, Learn, News

Psychedelic companies rely on novel patents to boost their value, but many players in the space are chasing the same IP

July 6, 2022June 2, 2024 Culture, Policy, Travel

As psychedelics continue to gain mainstream acceptance, these 5 states have started the process to legalize psychedelics

End of content